Apex Biotechnology

Apex Biotechnology EBIT

The EBIT of Apex Biotechnology (1733.TW) as of Nov 22, 2026 is 140.73 M TWD. In the previous year, EBIT was 128.51 M TWD — a change of 9.51% (higher).

EBIT

140.73 MTWD

YoY

9.51%

Last updated:

In 2025, Apex Biotechnology's EBIT was 140.73 M TWD, a 9.51% increase from the 128.51 M TWD EBIT recorded in the previous year.

The Apex Biotechnology EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2019
172.91 M TWD
Jan 1, 2020
120.53 M TWD
Jan 1, 2021
193.97 M TWD
Jan 1, 2022
204.97 M TWD
Jan 1, 2023
141.72 M TWD
Jan 1, 2024
128.51 M TWD
Jan 1, 2025
140.73 M TWD
Jan 1, 2026 (e)
838.71 M TWD
The Apex Biotechnology EBIT history
YEAREBITYoY
est838.71 MTWD+495.99%
140.73 MTWD+9.51%
128.51 MTWD-9.32%
141.72 MTWD-30.86%
204.97 MTWD+5.67%
193.97 MTWD+60.93%
120.53 MTWD-30.29%
172.91 MTWD-23.95%
227.35 MTWD+41.21%
161.00 MTWD-34.52%
245.89 MTWD-18.25%
300.80 MTWD+3.91%
289.49 MTWD-17.05%
348.99 MTWD-42.09%
602.60 MTWD+8.06%
557.64 MTWD-2.85%
574.03 MTWD+27.71%
449.46 MTWD+24.56%
360.85 MTWD-20.28%
452.63 MTWD+40.65%
321.81 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Apex Biotechnology Revenue

Apex Biotechnology Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
2.20 B TWD
172.91 M TWD
113.86 M TWD
Jan 1, 2020
2.01 B TWD
120.53 M TWD
94.80 M TWD
Jan 1, 2021
2.13 B TWD
193.97 M TWD
202.22 M TWD
Jan 1, 2022
2.24 B TWD
204.97 M TWD
181.79 M TWD
Jan 1, 2023
1.68 B TWD
141.72 M TWD
115.78 M TWD
Jan 1, 2024
1.85 B TWD
128.51 M TWD
128.00 M TWD
Jan 1, 2025
1.94 B TWD
140.73 M TWD
163.04 M TWD
Jan 1, 2026 (e)
12.55 B TWD
838.71 M TWD
741.99 M TWD

Apex Biotechnology Margins

Apex Biotechnology stock margins

The Apex Biotechnology margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Apex Biotechnology. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Apex Biotechnology.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
26.86 %
7.86 %
5.18 %
Jan 1, 2020
22.55 %
6.01 %
4.73 %
Jan 1, 2021
26.81 %
9.10 %
9.49 %
Jan 1, 2022
25.70 %
9.13 %
8.10 %
Jan 1, 2023
31.68 %
8.45 %
6.91 %
Jan 1, 2024
28.15 %
6.94 %
6.91 %
Jan 1, 2025
27.70 %
7.24 %
8.38 %
Jan 1, 2026 (e)
27.70 %
6.69 %
5.91 %

Apex Biotechnology Stock analysis

What does Apex Biotechnology do? Apex Biotechnology Corp is a Taiwan-based company specializing in the development of innovative biotechnology products. The company was founded in 2002 and offers a wide range of products and services to its customers. Apex Biotechnology Corp began with the production of specialty chemicals and enzymes for research and development purposes. Over the years, the company has expanded its business and focused on the development of diagnostic products, dietary supplements, and pharmaceutical products. The company's business model focuses on the development and marketing of biotechnology products. Apex Biotechnology Corp has established advanced research centers and works closely with research institutions and pharmaceutical companies worldwide to develop innovative solutions. The company operates in various sectors, including diagnostics, dietary supplements, and pharmaceuticals. It offers a diverse range of products, including enzyme immunoassays, lateral flow tests, dietary supplements, and pharmaceuticals. Apex Biotechnology Corp has built strong relationships with research institutions and pharmaceutical companies and has successfully marketed its products internationally. Apex Biotechnology is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Apex Biotechnology's EBIT

Apex Biotechnology's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Apex Biotechnology's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Apex Biotechnology's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Apex Biotechnology’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Apex Biotechnology stock

EBIT of Apex Biotechnology is 140.73 M TWD in 2025.

EBIT of Apex Biotechnology changed from 128.51 M TWD to 140.73 M TWD, representing a 9.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Apex Biotechnology since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Apex Biotechnology historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Apex Biotechnology

All Key Metrics — Apex Biotechnology